Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2240
-0.0050 (-2.18%)
Aug 7, 2026, 1:37 PM CET
Biotechnology Assets Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.09 | 3.16 | 0.53 | 2.61 | 3.09 | |
Revenue Growth | -2.10% | 494.28% | -79.67% | -15.28% | 22.21% |
Cost of Revenue | 0.23 | 0.31 | 0.02 | 0.32 | 0.25 |
Gross Profit | 2.86 | 2.84 | 0.51 | 2.29 | 2.84 |
Selling, General & Admin | 5.63 | 7.02 | 2.54 | 5.25 | 6.75 |
Depreciation & Amortization Expenses | 2.02 | 2.2 | 0.71 | 2.15 | 2.03 |
Other Operating Expenses | 0.48 | 0.24 | 3.4 | -0.48 | -0.56 |
Total Operating Expenses | 8.13 | 9.47 | 6.66 | 6.91 | 8.22 |
Operating Income | -1.41 | -2.71 | 3.55 | -1.73 | -2.07 |
Interest Income | 0 | 0 | 0.02 | 0 | 0.01 |
Interest Expense | -0.13 | -0.18 | -0.29 | -0.35 | -0.85 |
Other Non-Operating Income (Expense) | -0.06 | -0.05 | -1.01 | 0.03 | 0.01 |
Total Non-Operating Income (Expense) | -0.19 | -0.23 | -1.28 | -0.31 | -0.83 |
Pretax Income | -1.6 | -3.06 | 2.77 | -2.04 | -2.91 |
Provision for Income Taxes | 0.32 | -0.14 | 0.75 | -0.1 | 0.1 |
Net Income | -1.92 | -2.92 | 2.01 | -1.94 | -3.01 |
Minority Interest in Earnings | -0 | - | - | -0 | -0 |
Net Income to Common | -1.92 | -2.92 | 2.01 | -1.94 | -3.01 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 73 | 66 | 58 | 58 | 46 |
Shares Outstanding (Diluted) | 73 | 66 | 58 | 58 | 46 |
Shares Change | 10.20% | 14.28% | 0.05% | 26.49% | 16.39% |
EPS (Basic) | -0.03 | -0.04 | 0.03 | -0.03 | -0.07 |
EPS (Diluted) | -0.03 | -0.04 | 0.03 | -0.03 | -0.07 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -0.02 | -0.09 | -0.02 | -0.14 | -1.52 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.03 |
Gross Margin | 92.52% | 90.11% | 95.71% | 87.63% | 92.01% |
Operating Margin | -45.47% | -85.77% | 668.10% | -66.15% | -67.21% |
Profit Margin | -62.01% | -92.41% | 379.22% | -74.37% | -97.68% |
FCF Margin | -0.49% | -2.78% | -4.11% | -5.54% | -49.24% |
EBITDA | 0.61 | -0.5 | 6.01 | 0.42 | -0.04 |
EBITDA Margin | 19.76% | -15.95% | 1132.23% | 16.02% | -1.39% |
EBIT | -1.41 | -2.71 | 3.55 | -1.73 | -2.07 |
EBIT Margin | -45.47% | -85.77% | 668.10% | -66.15% | -67.21% |
Effective Tax Rate | -20.04% | 4.55% | 27.20% | 4.85% | -3.56% |